SCIENTIFIC SUMMITS
on urothelial, prostate and kidney cancer
5 June 2020 – 15h30 to 19h

Scientific Summits online conference 5 June 2020

We have the pleasure to invite you to our next Uro Scientific Summits conference on Friday 5 June 2020, from 15h30 to 19h. In the present circumstances and based on the information provided by the experts, we have decided to convert this meeting to an online symposium.

The meeting will be recorded and live-streamed with the help of a high profile technical partner, enabling speakers, attendees & experts to discuss in a virtual conference room.

Important novelties in the field of urothelial, prostate and kidney cancer will be covered by national & international top experts in the field.

Just like every year since 2016, our meetings will gather key opinion leaders, tackling hot topics related to urology & oncology, and bringing forward multidisciplinary discussions on the latest developments in the field. The full & detailed program can be found hereunder.

We look forward to welcoming you!
Steven, Lieven, Gert, Karel, Marc, Filip, Christof & Owen

Scientific Summits online conference
Friday 5 June 2020
15h30 — 19h

REGISTER NOW

Program

We’re delighted to announce that a large number of national & international top speakers have confirmed their presence for our program.

15h30
PART 1 — PROSTATE CANCER  (90 min)

The sense and non-sense of Retzius-sparing RALP

Dr. Christophe Assenmacher, Cliniques de l’Europe, Uccle

Updated results of high-dose rate brachytherapy in high-risk prostate cancer

Prof. Dr. Alberto Bossi, Institut Gustave Roussy, Villejuif

Postoperative radiotherapy after prostatectomy: is early salvage RT the new standard? What should we learn from RADICALS?

Prof. Dr. Cesare Cozzarini,Vita-Salute San Raffaele University Hospital, Milan

The place of surgery in mHSPC

Prof. Dr. Prasanna Sooriakumaran, University College London Hospital, London

Development and clinical implementation of PARP-inhibitors in PCa management

Prof. Dr. Joaquin Mateo, Vall d’Hebron Institute of Oncology, Barcelona

17h00
Short break

17h20
PART 2 — KIDNEY CANCER (45 min)

Time to abandon all cytoreductive nephrectomies?

Prof. Dr. Maarten Albersen, University Hospitals Leuven, Leuven

The changing first line treatment paradigm in metastatic clear cell renal cell cancer

Prof. Dr. Axel Bex, University College London, London

18h05
Short break

18h15
PART 3 — UROTHELIAL CANCER  (45 min)

The expanding role of RT in all stages of urothelial cancer

Prof. Dr. Valérie Fonteyne, University Hospital Ghent

Ongoing neo-adjuvant and adjuvant trials in Urothelial Bladder Cancer – The future looks bright

Prof. Dr. Tom Powles, Barts Cancer Institute, London

Surgical safety of radical cystectomy and PLND following neo-adjuvant immune checkpoint inhibitors

Prof. Dr. Alberto Briganti, Vita-Salute San Raffaele University Hospital, Milan

19h00
End

OUR SPONSORS

DIAMOND sponsors

GOLD sponsor

SILVER sponsors

BRONZE sponsors

SUPPORTING member